Posts tagged as:

DRGS

While some American’s were elated with Obama’s re-election, Wall Street made it quite clear who it had voted for as markets took a sharp nosedive in a post-election sell off immediately following the President’s victory. To many investors, Obama’s re-election has placed looming concerns over the Fiscal Cliff to the forefront, as the automatic round of massive spending cuts and tax hikes now seem inevitable come January 1. And with Democrats maintaining control of the Senate and Republicans dominating the House, many remain understandably concerned about the split Congress coming up with a viable resolution [see 101 ETF Lessons Every Financial Advisor Should Learn]. [click to continue…]

{ Comments on this entry are closed }

The third quarter got off to a sizzling start in the ETF industry; a surge in asset prices boosted asset levels significantly after two months of freefalls, and the product development activity remained strong after a busy month of September. Close to 30 new products began trading last month, including many first-to-market ideas that have opened up new asset classes and investment strategies. October additions to the ETF lineup are highlighted below. [click to continue…]

{ Comments on this entry are closed }

Markets this week rebounded as investors found new hope for the resolution of Europe’s debt crisis. Concerns were abated after the E.U. announced its plan to impose a 50% haircut on Greek bonds and to apply more leverage to their bailout fund. The week ended on a slightly weaker note as stocks eased back after Thursday’s incredible rally. In the […]

{ Comments on this entry are closed }

Bad Week To Be A Bear

by on October 29, 2011

The bulls came rushing back last week and equity indexes soared, bolstered by solid corporate earnings at home coupled with encouraging developments in the Euro zone. Investors were more than cheerful to see EU leaders take the first steps towards negotiating on a viable “rescue plan” to ensure stability in the financially fragile currency bloc. […]

{ Comments on this entry are closed }

RBS rolled out its fifth ETN this week, debuting a product that offers exposure to the world’s largest pharmaceutical firms. The new Global Big Pharma ETN (DRGS) will seek to replicate the NYSE Arca Equal Weighted Pharmaceutical Total Return Index, a benchmark that consists of equal allocations to about 16 different companies involved in various […]

{ Comments on this entry are closed }